Calumet Q2 sales beat estimates on demand for specialty products
Calumet Q2 sales beat estimates on demand for specialty products
Overview
US specialty products and renewable fuels maker's Q2 sales rose, beating analyst expectations
Q2 net loss narrows
Adjusted EBITDA more than doubled from last year
Outlook
Company expects to accelerate deleveraging and advance growth strategies across both businesses
Calumet sees a favorable margin environment in specialty products and renewables
Company remains focused on using cash from operations to pay down debt in future periods
Result Drivers
SPECIALTY SHORTAGE - Co said global shortage in specialty products, strong production and commercial execution drove Specialty Products & Solutions results
RENEWABLES EXPANSION - Montana Renewables completed first phase of MaxSAF 150 expansion and restarted operations in May, capturing robust renewable margins
PERFORMANCE BRANDS MARGIN PRESSURE - Record TruFuel sales offset by compressed margins due to price lag and higher feedstock costs
Company press release: ID:nPn1GrQTwa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales | Beat | $1.45 bln | $1.08 bln (4 Analysts) |
Q2 Loss Per Share |
| $1.09 |
|
Q2 Net Loss |
| $95.90 mln |
|
Q2 Adjusted EBITDA |
| $159.30 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the oil & gas refining and marketing peer group is "buy"
Wall Street's median 12-month price target for Calumet, Inc. is $36.00, about 14% below its August 6 closing price of $41.88
Reuters Recommended Reads
Aug 6 - Renewable fuels maker Gevo's Q2 revenue slightly beats estimates, lifts FY EBITDA outlook
Aug 5 - Montauk Renewables Q2 revenue beats estimates on higher RINs sales
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Calumet
See all newsBrief: Calumet - Mrl And Doe Enter First Amendment To Loan Guarantee Agreement On August 28, 2026 - SEC Filing
Calumet, Inc. reports results for the quarter ended June 30 - Earnings Summary
Calumet Q2 sales beat estimates on demand for specialty products
Brief: Calumet Q2 EPS USD -1.09
Calumet, Inc. expected to post a loss of 13 cents a share - Earnings Preview